Sertraline exerts its antitumor functions through both apoptosis and autophagy pathways in acute myeloid leukemia cells

References

• Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–257.
   PubMed Web of Science ®Google Scholar
• Fuchs Y, Steller H. Programmed cell death in animal development and disease. Cell. 2011;147:742–758.
   PubMed Web of Science ®Google Scholar
• Fulda S, Kögel D. Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy. Oncogene. 2015;34:5105–5113.
   PubMed Web of Science ®Google Scholar
• Ohsumi Y. Historical landmarks of autophagy research. Cell Res. 2014;24:9–23.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell. 2010;140:313–326.
   PubMed Web of Science ®Google Scholar
• Lockshin RA. Programmed cell death 50 (and beyond). Cell Death Differ. 2016;23:10–17.
   PubMed Web of Science ®Google Scholar
• Mariño G, Niso-Santano M, Baehrecke EH, et al. Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol. 2014;15:81–94.
   PubMed Web of Science ®Google Scholar
• Baig S, Seevasant I, Mohamad J, et al. Potential of apoptotic pathway-targeted cancer therapeutic research: where do we stand? Cell Death Dis. 2016;7:e2058.
   PubMed Web of Science ®Google Scholar
• Rebecca VW, Amaravadi RK. Emerging strategies to effectively target autophagy in cancer. Oncogene. 2016;35:1–11.
   PubMed Web of Science ®Google Scholar
• Granata S, Dalla Gassa A, Carraro A, et al. Sirolimus and everolimus pathway: reviewing candidate genes influencing their intracellular effects. IJMS. 2016;17:E735.
   Web of Science ®Google Scholar
• Saran U, Foti M, Dufour JF. Cellular and molecular effects of the mTOR inhibitor everolimus. Clin Sci. 2015;129:895–914.
   PubMed Web of Science ®Google Scholar
• Soria JC, Smit E, Khayat D, et al. Phase 1b study of dulanermin (recombinant human Apo2L/TRAIL) in combination with paclitaxel, carboplatin, and bevacizumab in patients with advanced non-squamous non-small-cell lung cancer. J Clin Oncol. 2010;28:1527–1533.
   PubMed Web of Science ®Google Scholar
• Wainberg ZA, Messersmith WA, Peddi PF, et al. A phase 1B study of dulanermin in combination with modified FOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer. Clin Colorectal Cancer. 2013;12:248–254.
   PubMed Web of Science ®Google Scholar
• Sanchez C, Reines EH, Montgomery SA. A comparative review of escitalopram, paroxetine, and sertraline: are they all alike? Int Clin Psychopharmacol. 2014;29:185–196.
   PubMed Web of Science ®Google Scholar
• Chen S, Xuan J, Wan L, et al. Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogen-activated protein kinase pathway. Toxicol Sci. 2014;137:404–415.
   PubMed Web of Science ®Google Scholar
• Gil-Ad I, Zolokov A, Lomnitski L, et al. Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice. Int J Oncol. 2008;33:277–286.
   PubMed Web of Science ®Google Scholar
• Amit BH, Gil-Ad I, Taler M, et al. Proapoptotic and chemosensitizing effects of selective serotonin reuptake inhibitors on T cell lymphoma/leukemia (Jurkat) in vitro. Eur Neuropsychopharmacol. 2009;19:726–734.
   PubMed Web of Science ®Google Scholar
• Lin CJ, Robert F, Sukarieh R, et al. The antidepressant sertraline inhibits translation initiation by curtailing mammalian target of rapamycin signaling. Cancer Res. 2010;70:3199–3208.
   PubMed Web of Science ®Google Scholar
• Kim ES, Shin JH, Park SJ, et al. Inhibition of autophagy suppresses sertraline-mediated primary ciliogenesis in retinal pigment epithelium cells. PLoS ONE. 2015;10:e0118190.
   PubMed Web of Science ®Google Scholar
• Fulda S. Targeting apoptosis for anticancer therapy. Semin Cancer Biol. 2015;31:84–88.
   PubMed Web of Science ®Google Scholar
• Kaplan C, Zhang Y. Assessing the comparative-effectiveness of antidepressants commonly prescribed for depression in the US Medicare population. J Ment Health Policy Econ. 2012;15:171–178.
   PubMed Web of Science ®Google Scholar
• Saletu B, Grunberger J, Linzmayer L. On central effects of serotonin re-uptake inhibitors: quantitative EEG and psychometric studies with sertraline and zimelidine. J Neural Transm. 1986;67:241–266.
   PubMed Web of Science ®Google Scholar
• Mandrioli R, Mercolini L, Raggi MA. Evaluation of the pharmacokinetics, safety and clinical efficacy of sertraline used to treat social anxiety. Expert Opin Drug Metab Toxicol. 2013;9:1495–1505.
   PubMed Web of Science ®Google Scholar
• Barbey JT, Roose SP. SSRI safety in overdose. J Clin Psychiatry. 1998;59 Suppl 15:42–48.
   PubMed Web of Science ®Google Scholar
• Amson R, Karp JE, Telerman A. Lessons from tumor reversion for cancer treatment. Curr Opin Oncol. 2013;25:59–65.
   PubMed Web of Science ®Google Scholar
• Tzadok S, Beery E, Israeli M, et al. In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells. Int J Oncol. 2010;37:1043–1051.
   PubMed Web of Science ®Google Scholar
• Schenk T, Chen WC, Gollner S, et al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat Med. 2012;18:605–611.
   PubMed Web of Science ®Google Scholar
• Mohammad HP, Smitheman KN, Kamat CD, et al. A DNA hypomethylation signature predicts antitumor activity of LSD1 inhibitors in SCLC. Cancer Cell. 2015;28:57–69.
   PubMed Web of Science ®Google Scholar
• Maes T, Carceller E, Salas J, et al. Advances in the development of histone lysine demethylase inhibitors. Curr Opin Pharmacol. 2015;23:52–60.
   PubMed Web of Science ®Google Scholar
• Zheng YC, Yu B, Jiang GZ, et al. Irreversible LSD1 inhibitors: application of tranylcypromine and its derivatives in cancer treatment. Curr Top Med Chem. 2016;16:2179–2188.
   PubMed Web of Science ®Google Scholar
• Tuynder M, Fiucci G, Prieur S, et al. Translationally controlled tumor protein is a target of tumor reversion. Proc Natl Acad Sci USA. 2004;101:15364–15369.
   PubMed Web of Science ®Google Scholar
• Telerman A, Amson R. The molecular programme of tumour reversion: the steps beyond malignant transformation. Nat Rev Cancer. 2009;9:206–216.
   PubMed Web of Science ®Google Scholar
• Acunzo J, Baylot V, So A, et al. TCTP as therapeutic target in cancers. Cancer Treat Rev. 2014;40:760–769.
   PubMed Web of Science ®Google Scholar
• Brown LF, Kroenke K, Theobald DE, et al. The association of depression and anxiety with health-related quality of life in cancer patients with depression and/or pain. Psychooncology. 2010;19:734–741.
   PubMed Web of Science ®Google Scholar